Taiko Pharmaceutical Co.,Ltd. (4574.T)
JPY 260.0
(-2.62%)
JPY 260.0
(-2.62%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2022 | 1.95 Billion JPY | -39.1% |
| 2021 | 3.2 Billion JPY | -49.99% |
| 2020 | 6.4 Billion JPY | 216.45% |
| 2019 | 2.02 Billion JPY | 31.47% |
| 2018 | 1.54 Billion JPY | 1.03% |
| 2017 | 1.52 Billion JPY | 10.07% |
| 2016 | 1.38 Billion JPY | -21.17% |
| 2015 | 1.75 Billion JPY | -19.43% |
| 2014 | 2.18 Billion JPY | 27.86% |
| 2013 | 1.7 Billion JPY | 21.95% |
| 2012 | 1.39 Billion JPY | 3.39% |
| 2011 | 1.35 Billion JPY | -11.39% |
| 2010 | 1.52 Billion JPY | -24.48% |
| 2009 | 2.02 Billion JPY | 49.36% |
| 2008 | 1.35 Billion JPY | 8.62% |
| 2007 | 1.24 Billion JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 Q2 | 1.83 Billion JPY | -7.26% |
| 2023 Q1 | 1.98 Billion JPY | 1.59% |
| 2023 Q3 | 1.58 Billion JPY | -13.65% |
| 2022 Q1 | 2.77 Billion JPY | -13.45% |
| 2022 FY | 1.95 Billion JPY | -39.1% |
| 2022 Q4 | 1.95 Billion JPY | -16.72% |
| 2022 Q3 | 2.34 Billion JPY | -6.76% |
| 2022 Q2 | 2.51 Billion JPY | -9.37% |
| 2021 Q2 | 5.89 Billion JPY | -22.16% |
| 2021 Q4 | 3.2 Billion JPY | -44.43% |
| 2021 Q3 | 5.76 Billion JPY | -2.09% |
| 2021 FY | 3.2 Billion JPY | -49.99% |
| 2021 Q1 | 7.56 Billion JPY | 0.0% |
| 2020 Q2 | 2.78 Billion JPY | 37.44% |
| 2020 FY | 6.4 Billion JPY | 216.45% |
| 2020 Q1 | 2.02 Billion JPY | -8.51% |
| 2020 Q3 | 4.7 Billion JPY | 69.22% |
| 2019 FY | 2.02 Billion JPY | 31.47% |
| 2019 Q1 | 1.54 Billion JPY | 0.08% |
| 2019 Q2 | 1.84 Billion JPY | 19.91% |
| 2019 Q4 | 2.21 Billion JPY | -0.53% |
| 2019 Q3 | 2.22 Billion JPY | 20.47% |
| 2018 FY | 1.54 Billion JPY | 1.03% |
| 2018 Q2 | 1.65 Billion JPY | 8.74% |
| 2018 Q1 | 1.52 Billion JPY | 6.11% |
| 2018 Q3 | 1.75 Billion JPY | 5.76% |
| 2018 Q4 | 1.53 Billion JPY | -12.23% |
| 2017 Q3 | 1.66 Billion JPY | 13.75% |
| 2017 FY | 1.52 Billion JPY | 10.07% |
| 2017 Q4 | 1.43 Billion JPY | -13.5% |
| 2017 Q2 | 1.46 Billion JPY | 5.43% |
| 2017 Q1 | 1.38 Billion JPY | 1.62% |
| 2016 Q4 | 1.36 Billion JPY | -28.57% |
| 2016 Q2 | 1.87 Billion JPY | 6.52% |
| 2016 Q3 | 1.9 Billion JPY | 1.95% |
| 2016 FY | 1.38 Billion JPY | -21.17% |
| 2016 Q1 | 1.75 Billion JPY | -2.57% |
| 2015 Q1 | 2.18 Billion JPY | 11.08% |
| 2015 Q4 | 1.8 Billion JPY | -13.56% |
| 2015 FY | 1.75 Billion JPY | -19.43% |
| 2015 Q2 | 2.31 Billion JPY | 6.35% |
| 2015 Q3 | 2.08 Billion JPY | -10.05% |
| 2014 Q2 | 1.92 Billion JPY | 12.67% |
| 2014 FY | 2.18 Billion JPY | 27.86% |
| 2014 Q3 | 1.98 Billion JPY | 3.17% |
| 2014 Q1 | 1.7 Billion JPY | 13.73% |
| 2014 Q4 | 1.96 Billion JPY | -0.98% |
| 2013 Q4 | 1.49 Billion JPY | -7.8% |
| 2013 Q1 | 1.39 Billion JPY | 12.73% |
| 2013 Q2 | 1.55 Billion JPY | 11.07% |
| 2013 FY | 1.7 Billion JPY | 21.95% |
| 2013 Q3 | 1.62 Billion JPY | 4.71% |
| 2012 FY | 1.39 Billion JPY | 3.39% |
| 2012 Q4 | 1.24 Billion JPY | 1.08% |
| 2012 Q3 | 1.22 Billion JPY | -5.83% |
| 2012 Q2 | 1.3 Billion JPY | -3.64% |
| 2012 Q1 | 1.35 Billion JPY | -3.92% |
| 2011 Q3 | 1.45 Billion JPY | -2.42% |
| 2011 Q4 | 1.4 Billion JPY | -3.05% |
| 2011 FY | 1.35 Billion JPY | -11.39% |
| 2011 Q2 | 1.48 Billion JPY | -2.52% |
| 2011 Q1 | 1.52 Billion JPY | -23.76% |
| 2010 FY | 1.52 Billion JPY | -24.48% |
| 2010 Q1 | 2.02 Billion JPY | 8.4% |
| 2010 Q2 | 2.13 Billion JPY | 5.42% |
| 2010 Q4 | 2 Billion JPY | -6.56% |
| 2010 Q3 | 2.14 Billion JPY | 0.57% |
| 2009 Q2 | 1.31 Billion JPY | -2.5% |
| 2009 Q3 | 1.43 Billion JPY | 8.88% |
| 2009 Q4 | 1.86 Billion JPY | 29.79% |
| 2009 Q1 | 1.35 Billion JPY | 0.0% |
| 2009 FY | 2.02 Billion JPY | 49.36% |
| 2008 FY | 1.35 Billion JPY | 8.62% |
| 2007 FY | 1.24 Billion JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 6.71 Billion JPY | 70.939% |
| Takeda Pharmaceutical Company Limited | 1209.86 Billion JPY | 99.839% |
| Sumitomo Pharma Co., Ltd. | 115.35 Billion JPY | 98.308% |
| Shionogi & Co., Ltd. | 64.91 Billion JPY | 96.993% |
| Wakamoto Pharmaceutical Co.,Ltd. | 2 Billion JPY | 2.694% |
| Nippon Shinyaku Co., Ltd. | 39.11 Billion JPY | 95.009% |
| Kaken Pharmaceutical Co., Ltd. | 17.16 Billion JPY | 88.629% |
| Eisai Co., Ltd. | 174.65 Billion JPY | 98.882% |
| Morishita Jintan Co., Ltd. | 3.18 Billion JPY | 38.713% |
| Hisamitsu Pharmaceutical Co., Inc. | 21.17 Billion JPY | 90.782% |
| Mochida Pharmaceutical Co., Ltd. | 30.27 Billion JPY | 93.553% |
| Fuso Pharmaceutical Industries,Ltd. | 14.2 Billion JPY | 86.255% |
| Nippon Chemiphar Co., Ltd. | 10.72 Billion JPY | 81.794% |
| Tsumura & Co. | 117.61 Billion JPY | 98.34% |
| Kissei Pharmaceutical Co., Ltd. | 26.29 Billion JPY | 92.577% |
| Torii Pharmaceutical Co., Ltd. | 10.74 Billion JPY | 81.828% |
| Towa Pharmaceutical Co., Ltd. | 101.07 Billion JPY | 98.069% |
| Fuji Pharma Co., Ltd. | 19.37 Billion JPY | 89.923% |
| Zeria Pharmaceutical Co., Ltd. | 14.48 Billion JPY | 86.528% |
| KYORIN Holdings, Inc. | 53.47 Billion JPY | 96.349% |
| Daito Pharmaceutical Co.,Ltd. | 20.89 Billion JPY | 90.656% |
| SymBio Pharmaceuticals Limited | 232.03 Million JPY | -741.271% |
| MedRx Co., Ltd | 10 Million JPY | -19420.0% |
| Mizuho Medy Co.,Ltd. | 1.59 Billion JPY | -22.259% |
| Solasia Pharma K.K. | 122 Million JPY | -1500.0% |
| Modalis Therapeutics Corporation | 6.35 Million JPY | -30625.641% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 20.4 Billion JPY | 90.432% |
| Sawai Group Holdings Co., Ltd. | 100 Billion JPY | 98.048% |
| Cyfuse Biomedical K.K. | 46.04 Million JPY | -4139.331% |
| Toho Holdings Co., Ltd. | 87.28 Billion JPY | 97.764% |
| Koa Shoji Holdings Co.,Ltd. | 2.26 Billion JPY | 13.867% |